ES2197500T3 - Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico. - Google Patents

Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico.

Info

Publication number
ES2197500T3
ES2197500T3 ES98941201T ES98941201T ES2197500T3 ES 2197500 T3 ES2197500 T3 ES 2197500T3 ES 98941201 T ES98941201 T ES 98941201T ES 98941201 T ES98941201 T ES 98941201T ES 2197500 T3 ES2197500 T3 ES 2197500T3
Authority
ES
Spain
Prior art keywords
treatment
dimethylamon
carbamoilmetil
phenyl
chronic pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98941201T
Other languages
English (en)
Inventor
Bernard A Macleod
David M J Quastel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Farchim SA
Original Assignee
UCB Farchim SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Farchim SA filed Critical UCB Farchim SA
Application granted granted Critical
Publication of ES2197500T3 publication Critical patent/ES2197500T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Uso de un compuesto para la preparación de un medicamento para el tratamiento o prevención del dolor crónico/no agudo en animales de sangre caliente incluyendo seres humanos, teniendo el compuesto la fórmula siguiente: en la que R1, R2, R3, R6, R7 y R8 se seleccionan independientemente de bromo, cloro, flúor, carboxi, hidrógeno, hidroxi, hidroximetilo, metanosulfonamido, nitro, sulfamilo, trifluorometilo, alcanoiloxi C2-C7, alquilo C1-C6, alcoxi C1-C6, alcoxicarbonilo C2-C7, N(R9, R10), fenilo y tioalquilo C1-C6; y donde R9 y R10 son independientemente hidrógeno, acetilo, metanosulfonilo o alquilo C1-C6; R4 y R5 se han seleccionado independientemente a partir de hidrógeno, alquilo C1-C8, alcoxialquilo C3-C8 y aralquilo C7-C12; X es el anión de la sal farmacéuticamente aceptable; o de sus isómeros enantioméricos, diastoméricos y geométricos aislados, o sus mezclas.
ES98941201T 1997-09-03 1998-09-03 Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico. Expired - Lifetime ES2197500T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5631297P 1997-09-03 1997-09-03

Publications (1)

Publication Number Publication Date
ES2197500T3 true ES2197500T3 (es) 2004-01-01

Family

ID=22003584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98941201T Expired - Lifetime ES2197500T3 (es) 1997-09-03 1998-09-03 Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico.

Country Status (12)

Country Link
EP (1) EP1009397B1 (es)
JP (1) JP2001514216A (es)
CN (1) CN1276722A (es)
AT (1) ATE238047T1 (es)
AU (1) AU8970198A (es)
BR (1) BR9812182A (es)
CA (1) CA2303815A1 (es)
DE (1) DE69813839T2 (es)
ES (1) ES2197500T3 (es)
HK (1) HK1028957A1 (es)
TW (1) TW536401B (es)
WO (1) WO1999011252A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2217742T3 (es) 1998-04-01 2004-11-01 Cardiome Pharma Corp. Compuestos de amino ciclohexil eter y usos del mismo.
BR9911094A (pt) * 1998-06-09 2001-10-30 Nortran Pharmaceuticals Inc Composições e métodos para o tratamento detosse
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
ES2264776T3 (es) 2003-05-02 2007-01-16 Cardiome Pharma Corp. Compuestos de aminociclohexil eter y sus usos.
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
US7674820B2 (en) 2003-08-07 2010-03-09 Cardiome Pharma Corp. Ion channel modulating activity I
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
EP1729815A2 (en) 2004-04-01 2006-12-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
US8263638B2 (en) 2004-11-08 2012-09-11 Cardiome Pharma Corp. Dosing regimens for ion channel modulating compounds
EP2101819B1 (en) * 2006-11-20 2013-01-09 President and Fellows of Harvard College Methods, compositions, and kits for treating pain and pruritis
CA3027255C (en) 2009-07-10 2022-06-21 The General Hospital Corporation Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
AU2020237474A1 (en) 2019-03-11 2021-09-30 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20220123381A (ko) 2019-11-06 2022-09-06 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP4118070A4 (en) 2020-03-11 2024-04-10 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
WO2023100836A1 (ja) * 2021-11-30 2023-06-08 マルホ株式会社 医薬組成物
KR20240110799A (ko) * 2021-11-30 2024-07-16 마루호 코 엘티디 의약 조성물

Also Published As

Publication number Publication date
JP2001514216A (ja) 2001-09-11
WO1999011252A3 (en) 1999-05-06
TW536401B (en) 2003-06-11
WO1999011252A2 (en) 1999-03-11
AU8970198A (en) 1999-03-22
HK1028957A1 (en) 2001-03-16
ATE238047T1 (de) 2003-05-15
DE69813839D1 (de) 2003-05-28
DE69813839T2 (de) 2004-03-04
CA2303815A1 (en) 1999-03-11
CN1276722A (zh) 2000-12-13
EP1009397A2 (en) 2000-06-21
EP1009397B1 (en) 2003-04-23
BR9812182A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
ES2197500T3 (es) Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico.
NO873243L (no) Legemiddel med antitumorvirkning.
DK293689A (da) Indretning i en justerbar stol
ATE185483T1 (de) Antivirale nucleosidkombination
DK163279C (da) Multimineralkosttilskudstablet med kontrolleret afgivelse
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
ES2123064T3 (es) Uso de melatonina en pequeñas dosis orales como somnifero.
BR9403783A (pt) Uso de uma composição cosmética
ES2177783T3 (es) Uso de la gabapentina y sus derivados en el tratamiento de mania y desorden bipolar.
DK332489A (da) Forbindelser med bronkodilatorisk virkning
MX9200431A (es) Azapironas:el uso en el desorden de hiperactividad de la falta de atencion.
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
DK165478C (da) Stol udstyret med omstilbar laegstoettedel
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
IT8619457A0 (it) Derivati insaturi cicloalifatici, loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica.
DK692087A (da) Peptid med renin-inhibitorisk virkning
NO964961D0 (no) Stol med justerbar rygg
DK222988D0 (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
KR920001961U (ko) 지압구를 부착시킨 의자용 팔걸이
ES1001099Y (es) Soporte ocultable en butacas y similares
KR880014656U (ko) 간이 책상이 부설된 절첩식 의자
ES503569A0 (es) Mejoras introducidas en el procedimiento de aireacion de aguas residuales y dispositivo para conseguir las mismas
KR830003548U (ko) 책상 및 의자 겸용 침대
NO883982D0 (no) Stillbar stol.